Jubilant gets FDA approval for antidepressant generic

Jubilant Life Sciences receives ANDA approval for Paroxetine Tablets


Jubilant's drug is the generic version of Apotex's Paxil tablets

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Paroxetine Tablets USP, 10 mg, 20 mg, 30 mg and 40 mg.

The tablets are the generic version of Paxil Tablets, 10 mg, 20 mg, 30 mg, and 40 mg (of Apotex), which is used as an antidepressant.

As on September 30, 2015, Jubilant Life Sciences had a total of 820 filings for formulations of which 391 have been approved in various regions globally.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email